Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 6.28B 931M 806M 750M 689M 1.3B 88.79B 1.33B 8.84B 3.47B 44.13B 3.5B 3.42B 147B P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 7.15B 1.06B 918M 854M 785M 1.48B 101B 1.51B 10.07B 3.96B 50.28B 3.98B 3.9B 167B EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day+0.88%
1 week+3.14%
Current month+5.99%
1 month+5.99%
3 months-8.55%
6 months+8.75%
Current year+5.75%
1 week 4.36
Extreme 4.36
4.63
1 month 4.31
Extreme 4.31
4.83
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.94
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 2015-04-01
Director of Finance/CFO 41 2020-12-28
Corporate Officer/Principal 42 2014-01-26
Director TitleAgeSince
Chairman 56 2026-03-26
Director/Board Member 58 2007-12-24
Director/Board Member 42 2014-01-26
Date Insider Type Main position Quantity % Market Cap.
9/21/20 Sell

Chairman

1,940,600 0.2495%
9/18/20 Sell

Director

3,670,000 0.4719%
9/18/20 Sell

Chairman

296,500 0.0381%
Change 5-day change 1-year change 3-year change Capi.($)
+0.88%+3.14%-14.81%-44.98% 920M
+0.21%+2.24%-7.94%-2.63% 13.92B
+0.15%+1.94%-28.44%-49.20% 5.33B
-1.12%+6.51%+4.48%+7.71% 5.21B
+1.56%-0.30%+2.24%-31.81% 4.11B
-0.03%+2.05%+0.82%-3.91% 3.79B
-0.33%-0.67%-2.58%-3.17% 3.67B
+1.51%+1.07%-2.72%+12.33% 3.51B
+0.90%-0.25%-14.25%-23.38% 2.44B
-2.04%+1.72%-1.20%+46.59% 1.96B
Average +0.17%+2.28%-6.44%-9.25% 4.48B
Weighted average by Cap. +0.16%+2.69%-6.60%-8.47%

Financials

2024 2025
Net sales 3.83B 567M 491M 457M 420M 793M 54.1B 808M 5.39B 2.12B 26.89B 2.13B 2.08B 89.27B 3.05B 452M 391M 364M 334M 632M 43.11B 644M 4.29B 1.69B 21.43B 1.7B 1.66B 71.14B
Net income 33.62M 4.98M 4.31M 4.01M 3.69M 6.97M 475M 7.1M 47.33M 18.59M 236M 18.72M 18.31M 785M -104M -15.47M -13.39M -12.46M -11.45M -21.64M -1.48B -22.04M -147M -57.71M -734M -58.11M -56.83M -2.44B
Net Debt 1.4B 208M 180M 167M 154M 290M 19.8B 296M 1.97B 774M 9.84B 780M 763M 32.68B 875M 130M 112M 104M 95.95M 181M 12.37B 185M 1.23B 484M 6.15B 487M 476M 20.41B
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
26-07-31 CN¥4.600 +0.88% 5,453,800
26-07-30 CN¥4.560 -0.44% 4,385,700
26-07-29 CN¥4.580 +0.88% 5,496,100
26-07-28 CN¥4.540 +1.79% 7,895,703
26-07-27 CN¥4.460 +1.13% 4,966,103

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock